Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5278825
Max Phase: Preclinical
Molecular Formula: C23H19N5S
Molecular Weight: 397.51
Associated Items:
ID: ALA5278825
Max Phase: Preclinical
Molecular Formula: C23H19N5S
Molecular Weight: 397.51
Associated Items:
Canonical SMILES: c1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1
Standard InChI: InChI=1S/C23H19N5S/c1-2-6-19(7-3-1)28-22(17-10-13-24-14-11-17)26-27-23(28)29-15-12-18-16-25-21-9-5-4-8-20(18)21/h1-11,13-14,16,25H,12,15H2
Standard InChI Key: PIKYRJSSRILQPF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 397.51 | Molecular Weight (Monoisotopic): 397.1361 | AlogP: 5.15 | #Rotatable Bonds: 6 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 3.71 | CX LogP: 4.90 | CX LogD: 4.90 |
Aromatic Rings: 5 | Heavy Atoms: 29 | QED Weighted: 0.40 | Np Likeness Score: -1.66 |
1. Yakkala PA, Panda SR, Naidu VGM, Shafi S, Kamal A.. (2023) Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer., 14 (3): [PMID:36923920] [10.1021/acsmedchemlett.2c00475] |
Source(1):